Chris J Reisenauer

Mayo Clinic

Papers

1

Total Citations

25

H-Index

1

About

Chris J. Reisenauer is a leading figure in interventional pulmonology and thoracic oncology, whose work centers on advancing the diagnosis and treatment of early-stage lung cancer. His primary research focuses on the evaluation of subsolid pulmonary nodules—including ground-glass and part-solid nodules—which are notoriously difficult to biopsy yet carry a high risk for malignancy. Reisenauer’s major contribution lies in pioneering comparative studies of shape-sensing robotic-assisted bronchoscopy against traditional computed tomography-guided transthoracic biopsy. His 2024 landmark paper on this topic, which has already garnered 25 citations, demonstrated that robotic-assisted approaches offer a safer, more accurate alternative for sampling these challenging nodules, potentially reducing complications while improving diagnostic yield. This work has profound implications for early lung cancer detection, where timely and precise biopsy is critical. Beyond this, Reisenauer is recognized for integrating cutting-edge robotic technologies into clinical practice, bridging the gap between engineering and bedside medicine. His research not only shapes current guidelines but also inspires a new generation of minimally invasive diagnostic strategies, making him a pivotal voice in the fight against lung cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Shape-Sensing Robotic-Assisted Bronchoscopy versus Computed Tomography-Guided Transthoracic Biopsy for the Evaluation of Subsolid Pulmonary Nodules
25 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago